Second-look operation in ovarian carcinoma: postchemotherapy

Cancer. 1976 Sep;38(3):1438-42. doi: 10.1002/1097-0142(197609)38:3<1438::aid-cncr2820380351>3.0.co;2-2.

Abstract

One hundred and three patients with advanced ovarian cancer underwent a second-look operation following chemotherapy. Patients should have ten or more courses of chemotherapy before second-look operation. Those patients with no evidence of disease at second laparotomy should discontinue their chemotherapy. Patients who continued chemotherapy after the second-look operation did better than those who were treated with radiation after surgery. Only patients with clinical remission benefit from the second-look procedure. Advantages of second-look operations following chemotherapy are discussed.

MeSH terms

  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Melphalan / therapeutic use
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / surgery*
  • Time Factors

Substances

  • Melphalan